Schwanebeck, Germany

Friedrich Luft


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Friedrich Luft: Innovator in Peptide Research

Introduction

Friedrich Luft is a notable inventor based in Schwanebeck, Germany. He has made significant contributions to the field of molecular medicine, particularly in the development of peptides for medical applications. His work focuses on addressing critical health issues such as preeclampsia and malignant hypertension.

Latest Patents

Friedrich Luft holds one patent that discloses peptides of the AT receptor. These peptides are designed for the elimination of specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malignant hypertension. The patent highlights the potential use of these peptides for the diagnosis of preeclampsia. Preferred peptide sequences include AFHYESQ (SEQ ID NO: 1), AVHYQSN (SEQ ID NO: 2), SHFYQTR (SEQ ID NO: 3), GYYFDTN (SEQ ID NO: 4), and ENTNIT (SEQ ID NO: 5).

Career Highlights

Friedrich Luft is associated with the Max-Delbrück-Centrum für Molekulare Medizin, where he conducts his research. His work has been instrumental in advancing the understanding of peptide applications in medical diagnostics and therapeutics.

Collaborations

Some of his notable coworkers include Gerd Wallukat and Volker Homuth, who have collaborated with him on various research projects.

Conclusion

Friedrich Luft's innovative work in peptide research has the potential to significantly impact the diagnosis and treatment of serious medical conditions. His contributions to molecular medicine are noteworthy and continue to inspire further research in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…